Lori Handy, MD, provides guidance in these areas including presentation before rash onset, when patients should be considered for the inpatient setting, and what treatment looks like.
|Videos|October 11, 2019
What to Expect in October's Multidrug-Resistant Infections Section of Contagion®
Author(s)Contagion® Editorial Staff
Samuel L. Aitken, PharmD, MPH, discusses the article he wrote with Dr. Sarah L. Spitznogle for the October issue of Contagion® evaluating the role of new β-lactam agents for uncommon pathogens.
Advertisement
Segment Description: Samuel L. Aitken, PharmD, MPH, clinical pharmacy specialist in infectious disease at The University of Texas MD Anderson Cancer Center, discusses the article he wrote with Dr. Sarah L. Spitznogle for the October issue of Contagion® evaluating the role of new β-lactam agents for uncommon pathogens.
Interview transcript: (modified slightly for readability)
Dr. Aitken: In the October issue of Contagion®, our PGY2 ID pharmacy resident Sarah Spitznogle and I take a look at the role of new beta-lactam/beta-lactamase inhibitors and the new beta-lactam agent cefiderocol against novel or difficult-to-treat non-lactose fermenters. So those are Stenotrophomonas, Achromobacter, and Burkholderia and, in that piece, we sort of take a mechanistic dive into why these things are resistant to so many different antimicrobials and, using that, can sort of form a basis for what drugs may or may not be active, understanding what drives beta-lactam resistance.
Advertisement
Related to this article
Jason Pogue, PharmD, BCPS, BCIDP, contextualizes preliminary data looking at this trial and other extended-spectrum beta-lactamase (ESBL) studies, which reopens the debate around carbapenem-sparing treatment options.
With a significant increase in rabies exposures this year, Rodney Rohde, PhD, talks about seeking medical attention after animal interactions as well as clinical treatment when people have been bit or scratched.
In the first episode of our new series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
Food expert Lynette Johnston, PhD, provides some context around the ongoing outbreak, discusses prevention, and compares 2026 food recalls with previous years.
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.
Advertisement
Advertisement